-
ETRA share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Price change
The price of ETRA shares has increased $0.67 since the market last closed. This is a 5.06% rise.
-
Last closed at $13.92.
The stock has since dropped $0.33 in pre-market trading.
Key terms
About ETRA
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
-
Market cap: $850.52M
A market capitalization between $300 million and $2 billion places ETRA in the small capitalization category.
Key terms
Smart score
Latest ETRA news
ETRA Financials
-
ETRA total revenue: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
ETRA net income: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
ETRA earnings per share: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
Key terms
ETRA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ETRA Competitors
-
How competitors are chosen
ETRA's competitors are included in the Health Technology sector and Pharmaceuticals: Major group
-
Market cap: $850.52M
A market capitalization between $300 million and $2 billion places ETRA in the small capitalization category.
